2nd Annual Clinical Trials Asia Summit 2011

2nd Annual Clinical Trials Asia Summit 2011

 

  • registration

    Sale Date Ended

    INR 5000
    Sold Out

Invite friends

Contact Us

Page Views : 3928

About The Event

“A critical guide for successfully conducting clinical trials”


Key Spekers

Arun Bhatt, President, Clininvent Research

Girish S. Gudi, Vice President, Drug Metabolism and Pharmacokinetics, Glenmark Pharmaceuticals

Zinobia Madan, Founder & Managing Director, ClinOma Healthcare

Mandeep S. Oberoi, President & CEO, Clintrials Research (USA)

Ammar Raza, Associate Director- Medical Affairs, AstraZeneca

Viraj Rajadhyaksha, Associate Director - Medical Liaison, Sanofi-Aventis

Arani Chatterjee, Vice President, Clinical Research, Panacea Biotec

Rohit Arora, Deputy Director, Sanofi Pasteur

Parminder Kaur, Managing Director, RegPak BioPharma Consulting (Netherlands)

Chirag Trivedi, Head - Medical Affaris Clinical Operations, Sanofi-Aventis

Kiran Marthak, Director, Veeda Clinical Research

Milind Antani, Head-Pharma LifeSciences group, Nishith Desai Associates

Shubhangi Desai, Associate Director, SIRO Clinpharm

S. K. Gupta, Director General & Dean, ICRI (Institute of Clinical Research India)

Rajesh Jain, General Manager & Head of Operations, ECCRO India Services

Murtuza S. Bughediwala, General Manager, Clinical Operations & Business Development, Clininvent Research

Poonam Sule, Senior Manager - Clinical Research (International), Wockhardt

Jeroze Dalal, General Manager Clinical Operations, GlaxoSmithKline

 

Conference Info

India has billion plus population and a home for various life threatening diseases. However, these disadvantages provide an opportunity for global medical practitioners and healthcare providers to look India as an effective destination for research and clinical studies. India has registered fast growth in the number of clinical trials over the past few years, reflecting that the country has become one of the most attractive destinations for medical research. India represents a fast growing market for clinical research and studies. The country has managed to position itself as one of the leading destinations for clinical trials over the past few years. The number of clinical trials has increased, which has provided a boost to the country’s reputation as a leading destination for these types of studies. The availability of world-class healthcare infrastructure, skilled medical professionals, and low cost for patients and volunteers are some of the main factors driving growth in this industry. The market is expected to perform well in future also and will reach US$ 768 Million by 2013, registering a CAGR of 29% since 2009.

2nd Annual Clinical Trials Asia Summit 2011 will examine the current issues faced in clinical trials operations, addressing the risks, timeline and budget stipulations, while effectively tackling key challenges in overcoming trials agreement and site contract arbitration problems. This summit will discuss the operational element of trial site management, strategic partnership with CROs and SMOs, patient, talent & investigators management in order to improve & optimise the overall drug development effectiveness and ROI. Discover on how to implement and benefit from electronic data management & monitoring cost effectively. This conference will be shared by leading industrial practitioners across the region to promote practical discussions; especially on the know-how to manage needs, variability of different countries and institutions to enhance clinical operational excellence and vigilance.

 Attendees will have the chance to learn, network and benchmark against the global top pharmas and local industry leaders on the best practices in talent, site, budget and performance management in clinical trials. The conference aims to provide a detailed analysis of what it takes to conduct clinical trials from a biopharmaceuticals and vaccines perspective in India and China and also addressing risk/benefit balance, anecdotal experiences of the multinational pharmaceutical industry in India and China, selection and role of CROs, logistics of operations, clinical trials management, government policies and pharmacovigilance.

2nd Annual Clinical Trials Asia Summit 2011 will provide you with the data that you need to recognize this complex and rapidly-expanding sector. Knowing the future market, and what impact will that have on future business opportunities? This is your opportunity to stay ahead by learning the latest trends and networking with the trend setters.

It gives us immense pleasure in welcoming you to the Clinical Trials Asia Summit '2011

Key themes discussed at this summit

  • Where does India stand in the current global clinical trials market and how to take advantage of the same? How can you take advantage of the global market for  clinical trials?
  • Discovering technologies and strategies for successful clinical trial management
  • Strategies in conducting successful interventional oncology trials in India
  • Setting up clinical trial research hub & techniques for applying risk management principles.
  • Discovering global opportunities in clinical trial and selecting the right partners to penetrate successfully into the Indian market
  • Identifying ideal clinical sites and strategizing patient recruitment and clinical sites management in India to develop appropriate clinical studies
  • Avoiding potential pitfalls of trials agreement
  • Regulatory review at the Drugs Controller General of India (DCGI) and Central Drugs Standard Control Organization (CDSCO): science, quality, and speed
  • Effectively incorporating GCP & GCPs – Knowing what TO-DO and what NOT TO-DO
  • Effectively managing cold chain and logistics in clinical trials
  • Optimising clinical trials operation effectiveness and ROI through strategic site, patient, data and risk management in the regulated markets
  • What are the issues with off-shoring trials to countries such as India & South Asia? – Solutions?
  • Motivating and managing clinical project teams to improve timeline and progress
  • Exploring the efficacy and safety of new interventions in clinical trials
  • Drawing and retaining clinical talent pool to minimise turnover in clinical studies
  • Next generation of clinical trials – How big will the market be?

Why should you attend

2nd Annual Clinical Trials Asia Summit 2011 - “A critical guide for successfully conducting clinical trials” 

 Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

Venue Map